PharMerica to Be Taken Private by KKR-Backed Company in $1.4 Billion Deal
02 Août 2017 - 2:34PM
Dow Jones News
By Bowdeya Tweh
KKR & Co. and Walgreens Boots Alliance Inc. have reached a
deal to take PharMerica Corp. private in a deal valued at $1.4
billion, the companies said Wednesday.
Shareholders of institutional pharmacy-services company
PharMerica will receive $29.25 a share in cash, a 17% premium to
Tuesday's closing price. Walgreens Boots Alliance will be a
minority investor in a newly formed company that KKR will
control.
Shares rose 15% to $28.75 in premarket trading.
The Louisville, Ky., company's decision to be acquired followed
a review of strategic alternatives. The company's board has already
approved the transaction.
"With the support of KKR and a strategic partner in Walgreens
Boots Alliance, PharMerica will have additional resources and
expertise to advance and grow the business," said Chief Executive
Gregory Weishar in prepared remarks.
The deal still requires PharMerica shareholder approval, but the
companies expect the acquisition to close by early 2018.
PharMerica on Wednesday also reported a second quarter adjusted
per-share profit of 47 cents on $592 million in revenue, compared
with a profit of 47 cents a share on $519.6 million in revenue a
year ago. Analysts polled by Thomson Reuters expected the company
to report an adjusted profit of 47 cents a share on revenue of $593
million.
Write to Bowdeya Tweh at Bowdeya.Tweh@wsj.com
(END) Dow Jones Newswires
August 02, 2017 08:19 ET (12:19 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Pharmerica Corp. (delisted) (New York Stock Exchange): 0 recent articles
Plus d'articles sur Pharmerica Corp.